AHCO
AdaptHealth Corp. · Healthcare · Medical - Devices
Momentum inputs (comparable managers):
holder breadth -20.0% ·
share flow -30.0% ·
net new positions -20.0%
· formula
Broad distribution: falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 109.95K | $661,406 | n/a | n/a |
| Q2 2026 | 90 | -1 | 72.87M | $759.46M | +5 | −6 |
| Q1 2026 | 94 | +1 | 70.41M | $837.57M | +8 | −7 |
| Q4 2025 | 93 | +1 | 73.49M | $731.97M | +1 | n/a |
| Q3 2025 | 16 | +1 | 45.46M | $406.86M | +2 | −1 |
| Q2 2025 | 12 | -1 | 44.17M | $416.50M | +2 | −3 |
| Q1 2025 | 10 | +2 | 8.72M | $94.54M | +3 | −1 |
| Q4 2024 | 8 | -2 | 7.78M | $74.03M | n/a | −2 |
| Q3 2024 | 9 | +1 | 7.21M | $80.97M | +1 | n/a |
| Q2 2024 | 8 | n/a | 4.34M | $43.45M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 4.47M | n/a | $42.53M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 2.47M | +0.7% | $23.50M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 3 | AQR Capital Management ✦ | 257.85K | +5.5% | $2.45M | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 4 | D. E. Shaw & Co. ✦ | 205.59K | -59.1% | $1.96M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Two Sigma Investments ✦ | 154.41K | -48.3% | $1.47M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 136.40K | -64.1% | $1.30M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 7 | T. Rowe Price ✦ | 73.99K | +16.4% | $705,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Bridgewater Associates ✦ | 11.68K | -71.3% | $111,146 | 0.0% | ▼ Trim | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Millennium Management | $36.12M | was 0.0% |
| Marshall Wace | $139,252 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 239 holders, 141.33M shares, $1.65B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
Director · 20.00K sh @ 5.86 · $117,200
Director · 20.00K sh @ 6.37 · $127,400
Director · 23.50K sh @ 6.38 · $149,930
Open-market sales (S)
No open-market insider sales in our coverage window.
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology